PUBLIC CONTRACT · 2019
Aquisição de Atosibano 37,5 mg/5ml Sol. Inj. Fr. 5ml IV e Atosibano 6,75mg/0,9ml Sol. Inj. Fr. 0,9ml IV
- Contract value
- €17,222.30
- Signed on
- 20 March 2019
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6058935PUBLISHED DESCRIPTION
41013919 - Aquisição de Atosibano 37,5 mg/5ml Sol. Inj. Fr. 5ml IV e Atosibano 6,75mg/0,9ml Sol. Inj. Fr. 0,9ml IV
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- FERRING PORTUGUESA-PROD. FARMAC.SOC.UNIP.,LDA. · Tax ID 502034831
Values and timeline
- Contract price
- €17,222.30
- Procedure base price
- €17,222.30
- Total effective price
- Not reported on Portal BASE
- Publication date
- 26 November 2019
- Award date
- 1 March 2019
- Signing date
- 20 March 2019
- Performance period
- 286 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Preço ou custo
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 20.º, n.º 1, alínea d) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4277607
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.